Skip to content
  • 6,837 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for cGMP Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing

75N91024D00008

National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Awarded

Curia Bio Inc.

$149,995,000.00 on the award notice, September 13, 2024, contract 75N91024D00008

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2024

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

This is an IDIQ award (with potential fixed-price and cost plus fixed fee task orders) associated with the CGMP Pool under the PREVENT Preclinical Drug Development Program awarded competitively.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Curia Bio Inc.
UEI
PW5LPREDN9N5
CAGE
9TMX2
Vendor location
Belmont, CA
Contract
75N91024D00008
Obligated
$0.00, potential $149,995,000
Actions
2 between September 13, 2024 and June 25, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
Prevent Cancer Preclinical Drug Development Program: CGMP
Match
award number 75N91024D00008 equals the contract number; same awarding office 75N910 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 16, 2024

    Award notice, originally solicitation

    Awarded to CURIA BIO Inc. Albany for $149,995,000. SAM.gov, notice 8f62eacf01814c149d890de2e0816392

Points of contact